FDA Approved: ENSTILAR — Original Application (LEO Pharma Inc.)

View source ↗

Summary

FDA approved ENSTILAR, a fixed-dose topical combination of calcipotriene and betamethasone dipropionate for psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Enstilar (calcipotriene; betamethasone dipropionate)

Snippet

ORIG AP for ENSTILAR (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)